Background and Purpose-Time to reperfusion is fundamental in reducing morbidity and mortality in acute stroke. We aimed to demonstrate that direct transfer to angio-suite (DTAS) of patients with suspected large vessel occlusion stroke improves workflow times and outcomes. Methods-A case-control matched study of the first 79 DTAS patients with confirmed large vessel occlusion (cases) and 145 no-DTAS patients (controls). DTAS protocol included a cone beam computed tomography in the angio-suite to rule out intracerebral hemorrhage for those patients with no prior neuroimaging in a referring center. Cases and controls were matched by location of vessel occlusion, age, baseline National Institutes of Health Stroke Scale (NIHSS) score and time from symptoms onset to Comprehensive Stroke Center arrival. Dramatic clinical improvement was defined as a decrease in NIHSS score of >10 points or final NIHSS score of ≤2. Favorable outcome was defined as modified Rankin Scale score of ≤2 at 90 days. Results-During an 18 months period a total of 97 patients were directly transferred to the angio-suite after admission: 11 (11.6%) showed an intracerebral hemorrhage on cone beam computed tomography, 7 (7.2%) did not have a large vessel occlusion on initial angiogram, and 79 (76.3%) had a large vessel occlusion and received endovascular treatment (cases). There were no differences in age, baseline NIHSS score, level of occlusion and time from onset-to-door between cases and controls. The median door-to-groin time (16 [12-20] 
I
t is now clear that in patients with large vessel occlusion (LVO) ischemic stroke, endovascular treatment (EVT) is associated with lower degrees of disability at 3 months. 1 Time to reperfusion is fundamental in reducing morbidity and mortality in patients undergoing revascularization therapies in acute stroke. 2, 3 Within the first 6 to 8 hours after symptoms onset the chances of functional recovery without disability decrease 10% to 15% for each 30 minutes delay to reperfusion. 4 Major efforts are being made to create EVT capable centers and to optimize the resources to reduce the time to recanalization. A previously described strategy to achieve time-saving consists in transferring patients directly to the angio-suite (DTAS) after admission leading to significant reduction of intrahospital times. 5, 6 In a previous work, in a smaller noncontrolled cohort, we demonstrated that DTAS is feasible, safe and achieves a significant reduction in-hospital workflow times
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that could be associated with a better chance of achieving good clinical outcomes. 7 In this study, we aimed to further explore the potential benefits of DTAS in a case-control study to have comparable patient populations at hospital arrival.
Methods
Starting February 2016 patients who undergo EVT in our Comprehensive Stroke Center follow 1 of 2 workflow protocols; either DTAS or no-DTAS. This case-control study compares the first consecutive 79 DTAS patients with confirmed LVO (cases) during an 18-month period (February 2016 to August 2017) with a 145 no-DTAS matched cohort of EVT patients (controls) treated in our institution from 2013. The study protocol was approved by the local ethics committee. Written informed consent was obtained. The data that support the findings of this study are available from the corresponding author on reasonable request.
Patients with suspected acute stroke presenting to our Comprehensive Stroke Center within the first 6 hours from symptoms onset and a Rapid Arterial Occlusion Evaluation 8 score ≥4 (reported by Emergency Medical System before admission) are DTAS if a rapid neurological exam confirms National Institutes of Health Stroke Scale (NIHSS) score >10 on arrival and the suite is immediately available. DTAS patients bypass the emergency department and the conventional computed tomography (CT) imaging. Once in the angio-suite a conebeam CT (Xpert-CT, high dose/fast acquisition, Allura Clarity FD 20/20 Philips 2015) is performed to exclude intracerebral hemorrhage for those patients directly admitted from the field. Whereas for those patients transferred from another institution, where previous neuroimaging has been acquired (noncontrast CT±CT angiography), cone-beam CT was not performed unless an evident clinical deterioration was observed during transfer. LVO was confirmed by an initial diagnostic cerebral angiogram. If LVO was not observed on initial angiogram in the expected artery according to neurological exam, patients underwent full angiographic evaluation of contralateral ICA and posterior circulation to rule out LVO in these vascular territories. When no occlusion was observed, EVT was aborted, and patients were treated accordingly. Only patients with confirmed LVO who underwent EVT were prospectively collected and considered as cases for this analysis. Controls were pulled from a prospectively maintained database of non-DTAS patients who underwent EVT in our hospital since 2013. Control patients followed the non-DTAS workflow protocol, which includes CT/CT angiography immediately after admission. Indication for EVT was based on ASPECTS score of >5 and identification of a treatable LVO. Time of symptoms onset, admission, groin puncture, and recanalization was recorded in all patients. DTAS and control patients received EVT in the same angio-suite (Allura Clarity FD 20/20 Philips 2015).
Each case was paired with 2 controls. To obtain comparable groups on admission, cases/controls were matched by LVO location (tandem ICA-cerebral artery, terminal ICA, M1-cerebral artery, M2-cerebral artery, and basilar), age (±2 years), baseline NIHSS score (±2 points), and time from symptoms onset to hospital arrival (±30 minutes; Table) . After these criteria, most cases (n=66) were matched with 2 controls; however, some cases could only be paired with 1 control (n=13) because of an insufficient number of matching controls.
Patients received intravenous-tPA (tissue-type plasminogen activator) when indicated, after either conventional CT scan or cone-beam CT. Independently of the admission protocol, endovascular procedures were performed by experienced interventionalists using commercially available stent retrievers and aspiration catheters. At the end of the procedure recanalization was assessed; complete recanalization was considered if the Thrombolysis in Cerebral Infarction score was 2b or 3.
Dramatic clinical improvement was defined as a decrease in NIHSS score of ≥10 points or NIHSS score of ≤2 at 24 hours. Favorable outcome was defined as modified Rankin Scale score of ≤2 at 90 days. Clinical worsening was defined as an increase of ≥4 points in the NIHSS score.
Statistical Analysis
Descriptive and frequency statistical analyses were obtained using SPSS V.17.0 software. Categorical variables are presented as absolute values and percentages and the continuous variables as mean 
Results
A total of 97 patients were directly transferred to the angiosuite during the study period. Eleven (11.6%) were intracerebral hemorrhage and 7 (7.2%) had no LVO after initial angiogram and were excluded from the analysis. The remaining 79 (76.3%) DTAS patients who presented an LVO and received EVT (cases) were matched to 145 non-DTAS controls resulting in a total of 224 patients. There were no significant differences on baseline characteristics between cases and controls, including age, baseline NIHSS score, time from symptom to admission, and occlusion location (Table) .
DTAS patients had a significantly shorter median door-topuncture time as compared with controls (16 [12] [13] [14] [15] [16] [17] [18] [19] [20] Figure 1 ).
At 24 hours DTAS patients had lower median NIHSS scores (7 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] versus 14 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ; P=0.02) and a higher rate of dramatic improvement (50.6% versus 31.7%; P=0.04). At 90 days DTAS presented better favorable outcome (modified Rankin Scale score of 0-2: 41% versus 28%; P=0.05; Figure 2 ). Safety was similar among the groups, there were no differences in the rate of clinical worsening (DTAS: 5.1% versus 13.5%; P=0.06) or symptomatic intracranial hemorrhage (DTAS: 2.5% versus 7.6%; P=0.12) after the procedure.
A logistic regression model adjusting for all matching variables (time from onset-to-arrival, LVO location, age, and baseline NIHSS score) showed that DTAS protocol was independently associated with 3 months favorable outcome (odds ratio, 2.5; 95% CI, 1.2-5.3; P=0.01).
Discussion
In this case-control study, we found that a DTAS workflow protocol for patients with suspected LVO stroke is safe, significantly shortens the door-to-groin time and improves the odds of a good clinical outcome as compared with a conventional neuroimaging workflow protocol.
Major efforts are being made by different stroke groups to reduce the door-to-groin time to increase the odds of good clinical outcome in patients with LVO undergoing EVT. 9 A meta-analysis on time to treatment highlighted the benefits of a short door-to-puncture time on patient outcomes after EVT. 10 The same study also showed great differences between centers in this workflow metric, suggesting that in-hospital organization of the treating teams is essential to achieve shorter times and better outcomes. These studies, however, kept conventional neuroimaging in their admission protocols precluding dramatic reductions of the door-to puncture times. A recent study suggested that a repeated neuroimaging protocol is not needed at the Comprehensive Stroke Center for transferred patients with an LVO confirmed at the primary stroke center.
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In a previous study, our group explored the safety and feasibility of a novel in-hospital selection workflow protocol consisting in transferring the patient directly to the angio-suite immediately after admission. 7 The study showed that substituting conventional neuroimaging by a cone-beam CT in the angio-suite allowed to safely achieve short door-to-puncture times and suggested improved outcomes. The findings were supported by others who explored similar admission protocols with encouraging clinical results. 5, 6 However, these studies were flawed by inclusion biases related to admission baseline unbalances between DTAS and non-DTAS patients, such as time from onset, stroke severity or other patient characteristics, precluding strong conclusions related to clinical benefits.
In the present study, we aimed to further explore the potential beneficial clinical effects of a DTAS protocol. To minimize the mentioned inclusion biases, we designed a study matching cases and controls according to the most relevant factors associated with outcome on admission. In the present study, after the DTAS protocol, we were able to substantially reduce the door-to-groin time to 16 minutes and, therefore, reduce the total time to reperfusion. This led to a door-to-grointime notably below current recommendation that suggests a goal of <60 minutes.
The study confirms the safety of DTAS that also emerges as a powerful predictor of favorable outcome by significantly reducing door-to-puncture times. The benefits were already seen at 24 hours and lasted until 3 months from stroke.
In line with prior observations, the study confirms the efficiency of clinical scales for a rapid triage of candidate patients before entering the angio-suite. 8 The use of prehospital scales, such as RACE, is necessary to activate the receiving team and initiate preparations before patient arrival. A rapid NIHSS assessment (NIHSS score >10) by the stroke unit team on arrival is used as a second filter before transferring the patient to the angio-suite. This selection algorithm (added to the fact that some of the patients were initially imaged at the primary stroke center) showed that up to 3 out of 4 selected patients will end up having an LVO and receiving an effective EVT. The remaining patients that finally did not show an LVO represent the price to pay to achieve the remarkable time reduction in the others. Also, the absolute priority given to DTAS patients may stress the team and cause delays in nonacute procedures scheduled in the same angio-suite. For this reason, if DTAS protocols confirm their benefits, it may be reasonable to create exclusively dedicated 1-stop angio-suite stations to evaluate and treat acute stroke patients admitted in high volume centers.
In patients with suspected acute stroke, the initial urgent evaluation process to indicate EVT is oriented to rule out an intracerebral hemorrhage and confirm the absence of a large irreversible lesion (ASPECTS <5) combined with the confirmation of an LVO. Last generation cone-beam CT seems sufficient to identify an intracerebral hemorrhage or an evident large parenchymal hypodensity. 12, 13 Moreover, a recent study showed that among acute ischemic stroke patients the rate of ASPECTS >5 that would support EVT indication progressively decreases over time but remains >90% within the first 6 hours from symptom onset.
14 Other studies even suggest that patients already showing low ASPECTS scores on admission may also benefit from EVT. 15, 16 Under these circumstances, long selection workflow protocols may harm the vast majority of eligible patients to exclude a minority that would probably not be harmed by the treatment. To definitively prove the benefits of DTAS protocols randomized studies are needed, and the time to start them should not be delayed anymore.
The present study was performed in a single center, with a very high volume of cases (>250 EVT/y) and, therefore, the results may not be applicable to other centers. Also, to perform optimal prehospital screening and Comprehensive Stroke Center notification before arrival, regional EMS needs to be familiar with a prehospital scale and use it routinely. Unfortunately, this is not always possible, and, therefore, results may not be applicable to all regions. To definitively confirm or deny the benefits of a DTAS protocol a multicentric randomized study should be performed.
Conclusions
Based on our results, we suggest that all patients with suspected acute stroke presenting within the first 6 hours of symptoms onset and a Rapid Arterial Occlusion Evaluation score ≥4 may benefit from DTAS. This measure showed to dramatically reduce the door-to-groin time, the door-to-reperfusion time, and the odds of good clinical outcome. The present accumulated evidence grants the development of future randomized trials for final confirmation of the benefits of DTAS protocols.
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